The areas of research that a clinician scientist proposes for funding through the AACSF grant program are not limited to patient-oriented, human subject research, but may also include translational research specifically designed to develop treatments or enhance diagnosis of neurological disease. These translational areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, mapping disease features or spread the development of new technologies and health services and outcomes research.
Disease related basic science studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
This grant is open to U.S. and international researchers.
Letter of Intent deadline: March 6, 2023; Sep. 6, 2023